Kidney Disease Outcomes Quality Initiative guidelines currently recommend the use of ACE inhibitors in the preservation of RKF and in the control blood pressure in patients with RUVs in excess of 100 ml [16]. The gene discussed is ACE; the disease is kidney disorder.